Winton Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
BIT
Winton Capital Management's PFE Position: Q1 2014 in Review
Winton Capital Management increased its Pfizer (PFE) stake by 35% in Q1 2014, buying an estimated $21.5M and bringing the position to 2,775,073 shares worth $84.6M. The position accounts for 0.58% of the portfolio, ranked #19.
Winton Capital Management first reported a position in PFE in Q2 2013 and has held it in 4 quarters since. 1,781 funds tracked by Wall St. Rank hold PFE as of Q1 2014.
- Winton Capital Management held 2,775,073 shares of Pfizer worth $84.6M as of Q1 2014.
- Winton Capital Management bought 721,983 Pfizer shares in Q1 2014, an estimated $21.5M.
- Pfizer made up 0.58% of Winton Capital Management's portfolio in Q1 2014, its #19 holding.
- Winton Capital Management first reported a position in Pfizer in Q2 2013 and has held it in 4 quarters since.
- 1,781 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.
Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.